Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The Value of Cytology for the Follow-Up of Prostatic Cancer after Hormone and Irradiation Therapy
Ist Teil von
European urology, 1985-01, Vol.11 (4), p.224-227
Ort / Verlag
Basel, Switzerland: Elsevier
Erscheinungsjahr
1985
Quelle
MEDLINE
Beschreibungen/Notizen
In a prospective study 162 patients with localized or metastasizing carcinoma of the prostate were followed
by fine-needle biopsies for cytological control of the therapy. 74 patients were treated by external beam irradiation
(6,000-7,000 cGy rotation technique), 88 patients by hormone therapy. Cytologic regression grading was correlated
with the clinical course during 3-6 years. The study shows a good correlation between the cytologic regression
grade 1 year after irradiation and the clinical course. A poor regression grade (still visible tumor cells) 1 year after
irradiation was followed by rapid tumor progression in more than 70%. In these cases early introduction of additional
therapy should be considered. After hormone therapy the correlation of the cytologic regression grade with the clinical
course is lower. Marked cytologic regression was associated with rapid tumor progression in about 60%, while poor
regression grading was followed in about 50% by a satisfactory course. Fine-needle aspiration biopsy and grading of
cytological regression is useful for follow-up of prostatic cancer after irradiation therapy. After hormone treatment, the
grade of cytological regression does not reflect the prognosis of the disease sufficiently, thus other clinical, enzymatic
and scintigraphic parameters have to be examined especially in cases with primary evidence of a metastasizing cancer
of the prostate.